Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. - Wikidata - awgldk - TriplyDB

Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate.

Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate.

http://www.wikidata.org/entity/Q36911036

about

Warfarin related nephropathy: a case report and review of the literature Warfarin-related nephropathy induced by three different vitamin K antagonists: analysis of 13 biopsy-proven cases.The occurrence of warfarin-related nephropathy and effects on renal and patient outcomes in korean patients.Correlates and outcomes of warfarin initiation in kidney transplant recipients newly diagnosed with atrial fibrillation Anticoagulation in chronic kidney disease patients-the practical aspects.Pathogenesis of glomerular haematuria.Risk of renal failure with the non-vitamin K antagonist oral anticoagulants: systematic review and meta-analysis.Haematuria increases progression of advanced proteinuric kidney disease.Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation.Wound Healing in Patients With Impaired Kidney Function.Dabigatran-Related Nephropathy in a Patient with Undiagnosed IgA Nephropathy Changes in the clinical presentation of immunoglobulin A nephropathy: data from the Spanish Registry of Glomerulonephritis.The Indian consensus guidance on stroke prevention in atrial fibrillation: An emphasis on practical use of nonvitamin K oral anticoagulants Anticoagulants and acute kidney injury: clinical and pathology considerations.Haematuria on the Spanish Registry of Glomerulonephritis.Warfarin slows deterioration of renal function in elderly patients with chronic kidney disease and atrial fibrillation.Whether Warfarin Therapy is Associated with Damage on Renal Function in Chinese Patients with Nonvalvular Atrial Fibrillation.The emerging role of coagulation proteases in kidney disease.Understanding and Managing Atrial Fibrillation in Patients with Kidney Disease.Membranous nephropathy: Pilot study of a novel regimen combining cyclosporine and Rituximab.Haematuria: the forgotten CKD factor?Differential diagnosis of glomerular disease: a systematic and inclusive approach.Oral anticoagulants and risk of nephropathy.Anticoagulation-related nephropathy.Use of direct oral anticoagulants in patients with nonvalvular atrial fibrillation according to clinical profile.Dabigatran etexilate: appropriate use in patients with chronic kidney disease and in the elderly patients.Antithrombotic medications in dialysis patients: a double-edged sword.Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association.Anticoagulant-related nephropathy: a case report and review of the literature of an increasingly recognized entity.Warfarin-related nephropathy: possible role for the warfarin pharmacogenetic profile.Warfarin-related nephropathy in a patient with mild IgA nephropathy on dabigatran and aspirin.Atrial fibrillation and chronic kidney disease: focus on rivaroxaban.5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy.Warfarin related acute kidney injury: A case report Haematuria and acute kidney injury in elderly patients admitted to hospital with supratherapeutic warfarin anticoagulation.Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Con.Drug-Induced Kidney Injury in the Elderly.Warfarin-related nephropathy is the tip of the iceberg: direct thrombin inhibitor dabigatran induces glomerular hemorrhage with acute kidney injury in rats.Oral warfarin and the thrombin inhibitor dabigatran increase blood pressure in rats: hidden danger of anticoagulants?Anticoagulating atrial fibrillation patients: is there a kidney-friendly choice?

P2860

Q28070365-E1272CBD-2504-4B1A-9FCF-DFA736DF4741 Q33783154-241A6742-92FD-4B25-BD36-60640F511A11 Q34656118-074D61D7-C1EC-4D7D-BFB0-E0490565DFC8 Q35055177-3AEECD25-FF23-41B5-8CCF-D9F0C8692AD7 Q35232128-015ADC2B-4D7A-4972-8503-D08E28C7CA10 Q35567846-9BE6A3AC-8183-4720-B986-1ADBD1008221 Q35640960-F6B9DAED-E411-480E-AF23-17731E76DE46 Q35643248-D3E9AF5E-B234-468B-976F-5BB7540A5E4C Q35758292-88F3B4B8-1E39-42B8-BF7A-FF79A032C98B Q35831040-5EA7C367-3BB0-4796-8414-2D4C6B88CC45 Q35968902-3BDB531A-B4A2-45F6-8A71-FEF5E2DBEC2D Q36359848-BFC6DDBF-FF42-42A2-A983-21E15AE1AF33 Q36396649-C37D1F82-68C1-4E9E-B4CD-D7F37738D52D Q36466324-B3D35FA3-100D-404B-9696-BC91E7177134 Q36511959-714EAE10-45D3-48E2-98F5-D31C8196B348 Q36851402-E300DBE8-351C-4A25-A076-3829362BD927 Q36930115-DE683609-1E6D-492D-9B0B-0C8C3454031C Q37066587-A14CFA67-F6A9-4973-A740-3C5AEAF89F79 Q37115706-C9B3A3EE-19BF-43B3-AEE2-7F9AE55E6305 Q37475696-9528CFE3-8ECA-4DA5-9B82-64E5E91EAA70 Q37979775-66EBE6C2-7B06-46D6-9A3C-C83A7E033C79 Q38139836-739AC364-9BC4-4304-8525-3A6280C197FE Q38443104-2351A8B3-EAD0-4872-9480-7D21839EC6CB Q38670098-C0DFDFAC-D4AF-4EB5-96C9-5CDD1D6AE2AF Q38812464-7DA253FF-57E1-47FC-8032-3BF932C66233 Q38821650-1B74DB99-E80D-478B-89A0-547053A43D1D Q38918821-7DCD3141-698B-43C3-935F-1F510A909152 Q38975409-DCB19E58-581B-4E5E-9D49-07E673445061 Q39120056-3DC7962A-A636-4F06-8467-68912FACBBA8 Q39368933-AEAF21B1-E1CD-414B-81FC-70CB3A2A7956 Q40787630-5FCABB61-7586-4C57-BFF7-77813B80E9D1 Q41341319-B21F8085-5177-49D7-8912-28F83D7CF1FB Q41551449-2F5EBBC1-1586-4D57-9DA1-6C1E66AA2798 Q42328633-AD523317-6A0D-4583-B189-CBD1253C318B Q43685010-B51D9345-695D-476F-8040-3FD66F08BECE Q44928316-E6647E41-2956-490A-B014-1C5279F3A796 Q45065480-8CC44D91-A331-42D3-A62C-064C13536F14 Q45835915-3FA539BE-2654-4E91-8D24-EB61D7746B47 Q46220670-97FC4E2F-8B5B-4709-B70B-5345A15CB662 Q47124161-F2872557-E20E-4CDD-B172-8AD975F26C99

P2860

Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate.

http://www.wikidata.org/entity/Q36911036

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Warfarin-related nephropathy o ...... h an increased mortality rate.

@en

type

label

Warfarin-related nephropathy o ...... h an increased mortality rate.

@en

prefLabel

Warfarin-related nephropathy o ...... h an increased mortality rate.

@en

P1433

Q36911036-74C821AA-3275-460C-BE95-7623CAFBCFC4

P1476

Q36911036-24D981C5-A5E2-42B9-ABCB-85FC0FB11FED

P2093

Q36911036-0828EA1B-4C55-49AC-A614-5A4BD85628D3

Q36911036-20529874-BD67-4F0B-9767-D6663B1E6BFE

Q36911036-24B59361-A39E-47D5-ACEB-D69C2EDF854C

Q36911036-2D93BAA8-9C60-4EDE-BE48-EA414D4E9EF4

Q36911036-56714CFC-62FE-4D8E-BEF0-E09DA989BA23

Q36911036-74D2E929-1EA4-4B1F-8B63-29524DBE6361

Q36911036-8FF1F1BC-8C29-4481-97B1-8A77C741A0E6

Q36911036-9D3FF441-5946-4A25-9B16-4DE1B93C7A06

P2860

Q36911036-0BE20EA4-7323-4119-A605-9021C59FCBDB

Q36911036-1C1810CE-875A-4887-9C58-FF67DBC762FA

Q36911036-1F4DAE15-CB70-4A1B-8C51-71CB08BDF186

Q36911036-4F3712ED-10B8-494B-935D-9F2905190C5A

Q36911036-52CA47EC-0AC2-49F4-9C7A-72E63878C4AE

Q36911036-585670EA-C66A-4BE8-8C6F-4AF8F39C5C81

Q36911036-6F0979D8-45E4-4DCC-B565-599169346223

Q36911036-8C6414FE-C360-416B-8736-22FBA38CDF0F

Q36911036-B4DE82D3-562C-474A-A125-38BAC046D855

Q36911036-B85BFE9B-70F5-4433-A22A-BBBBBE6786B5

P2888

Q36911036-8AA3C42C-7F17-4261-A637-08A7189AAEE9

P304

Q36911036-5072ACF9-80AD-48F7-AD4D-C64315CF0C62

P31

Q36911036-F31BC2E9-F544-45B9-898A-DD539BAF4869

P356

Q36911036-B8002D58-AD9A-42F8-A7EB-117855C86B04

P407

Q36911036-1CCA3EBD-9D31-4722-A64E-20AD3BFFE497

P433

Q36911036-C3689CA4-6759-4E26-87B2-9712D0E7C43A

P478

Q36911036-474E3E29-7E70-4D31-8FDA-0CBAAE866CB2

P577

Q36911036-30C87973-1820-4506-952F-2CAD376B68EB

P5875

Q36911036-69A54A61-9CA6-429A-AAB9-DF0FA390C8A1

P698

Q36911036-873A1EE3-DCEC-491E-906E-59B33A128A06

P932

Q36911036-3848DBE0-B020-4E56-AE86-C83323F4826F

P356

P1433

Kidney International

P1476

Warfarin-related nephropathy o ...... h an increased mortality rate.

@en

P2093

Anjali A Satoskar

http://www.w3.org/2001/XMLSchema#string

Brad H Rovin

http://www.w3.org/2001/XMLSchema#string

Gyongyi M Nadasdy

http://www.w3.org/2001/XMLSchema#string

Haifeng M Wu

http://www.w3.org/2001/XMLSchema#string

Lee A Hebert

http://www.w3.org/2001/XMLSchema#string

Sergey V Brodsky

http://www.w3.org/2001/XMLSchema#string

Tibor Nadasdy

http://www.w3.org/2001/XMLSchema#string

Udayan Y Bhatt

http://www.w3.org/2001/XMLSchema#string

P2860

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

A new equation to estimate glomerular filtration rate

Gas6, warfarin, and kidney diseases.

Cholesterol emboli associated with warfarin treatment.

Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action.

Kidney function influences warfarin responsiveness and hemorrhagic complications.

Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients.

Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation.

An unusual cause of gross hematuria and transient ARF in an SLE patient with warfarin coagulopathy.

Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases.

P2888

P304

181-189

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/KI.2011.44

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50351989

http://www.w3.org/2001/XMLSchema#string

P698

21389969

http://www.w3.org/2001/XMLSchema#string

P932

3675881

http://www.w3.org/2001/XMLSchema#string